Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational ...

WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...

Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

A bipartisan, bicameral group of senators have introduced legislation that would give the president new authority to ...

Eli Lilly has reduced the prices of certain Zepbound ... By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage ...

Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.

The latest health news features Eli Lilly's $27 billion plant investments amid tariff threats, Teleflex's division into two, and USAID's global health service cuts. In the U.S., a Texas child dies ...

JD.com, Eli Lilly and Company, Abbott Laboratories, Veeva Systems, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.